PureCycle Technologies, Inc. (PCT) stock intrinsic value fair value estimate & owner earnings analysis

PureCycle Technologies recycles used polypropylene, the plastic in tubs, caps and many food containers, with a solvent-based purification process that removes color, odor and contaminants. The output is a resin it sells as PureFive. It has one commercial plant, in Ironton, Ohio. The plant was designed to make about 107 million pounds a year and reached mechanical completion in 2023. The company says the plant is still not running at full capacity. It points to intermittent mechanical problems, including the rate at which other plastics and additives can be removed and difficulty sustaining continuous operation. A feedstock preparation site in Denver, Pennsylvania opened in September 2024, and the FDA issued further no-objection letters in 2025 that broaden the food-contact uses of the resin. What the business has actually earned: 2025 was the first year with revenue, at $8.4 million. Revenue in the first half of 2026 was $8.6 million, up from $3.2 million a year earlier. The operating loss did not narrow: it was $83.1 million in the first half of 2026 against $83.3 million a year earlier. We measure owner earnings as operating cash flow, minus working-capital swings, minus stock compensation, minus the capital spending needed to keep the plant running. Because there was little or no revenue, the usual method for splitting capital spending into upkeep and growth does not work here. We therefore treated upkeep spending as equal to depreciation, and counted the spending that built Ironton as growth. Large non-cash swings in the value of the company's warrants, such as a $61.7 million gain in 2025 and a $71.6 million loss in 2024, are excluded because they are not business cash. On that basis owner earnings were about -$130 million in 2023 (-$0.79 a share), -$181 million in 2024 (-$1.09) and -$198 million in 2025 (-$1.10). Before interest, the business itself consumed about $116 million, $138 million and $162 million in those years, and roughly $76 million in the first half of 2026. We use 2023 to 2025 as the reference window because those are the years with a completed plant. The median is a cash drain of about $0.84 a share per year before interest. The loss widened by about 10% in 2025. We do not assume it improves faster than the first half of 2026 shows, which works out to about $150 to $155 million a year. What was left out: the company plans a 130 million pound plant in Rayong, Thailand with IRPC (permitting under way, targeted for late 2027), a 130 million pound plant in Antwerp, Belgium (permit application planned for 2026, targeted for 2028) and a redesigned 300 million pound line in Augusta, Georgia (targeted for 2030). None of these is built or fully financed, so none is counted. In 2025 the company wrote down $15.1 million of equipment bought earlier for Augusta. The company prices its supply contracts with a formula meant to pass through feedstock and conversion costs. However, the filings disclose no selling price, volume or margin from which Ironton's profit at full output could be estimated, so no future profit is credited in any case. What it owes, ahead of common shareholders, using the June 30, 2026 balance sheet and later dividend accruals: - $287.5 million of 4.75% convertible notes due July 2032 (conversion near $11.08), issued in June 2026 - $34.0 million of 7.25% Green Convertible Notes still outstanding, which holders can put back for cash on August 15, 2027 - $35.8 million of 7% revenue bonds - $110.7 million of revenue bonds held by a related party at 6.5% to 13%, maturing through 2042 - $2.2 million of other debt - Series A preferred that must be redeemed in cash for about $57 million (54,003 shares at $1,050) on September 13, 2027 - $300 million of 7% Series B convertible preferred issued in June 2025, whose value accrues in kind to about $327 million today. It converts at $14.02 per share. We add about $55 million because the perpetual Series B compounds at 7%, above our 6% rate. We subtract about $18 million because the 2032 notes carry a coupon below 6%. Against this sits $224.8 million of cash and short-term securities. Net claims come to about $666 million, or $3.32 per share on 200.9 million shares. Bear case: Ironton stays where it has been since 2023. The business consumes about $160 million a year for three more years. The company keeps funding it with new stock and debt, as it did in each year from 2022 through 2026, until the burn is stopped by restructuring, and no lasting earning power is left behind. The business is worth about -$428 million, and it owes a net $666 million, so shareholders face a gap of about $1.09 billion, or -$5.45 a share. Base case: the ramp continues along its demonstrated path. Revenue keeps growing from a small base but losses shrink only modestly, to about $155 million and then $125 million. The August–September 2027 cash calls (about $91 million for the Green note put and the Series A redemption) force a funding decision, after which there is no evidenced earning power to credit. The business is worth about -$258 million against $666 million owed, a gap of about $924 million, or -$4.60 a share. Bull case: the plant's own levers work. Reliability improves, output climbs toward design rate, and the cost-pass-through contracts close the plant-level loss. The burn falls to about $150 million and then $75 million before reaching breakeven. Because no disclosed figure supports a specific profit at full output, nothing is credited after that. The business is worth about -$208 million against $666 million owed, a gap of about $875 million, or -$4.35 a share. In every case the company appears to owe more than the business can be shown to be worth, by roughly $0.9 to $1.1 billion. Most of that gap is the debt and preferred stock issued to build and run the company. Any value in the shares depends on Ironton becoming profitable or on the planned plants being built. The business has not yet demonstrated either. No margin-of-safety price is supported until that changes. What would prove this wrong: two or more quarters of Ironton running near design rate with positive cash flow before interest, plus disclosure of the price and margin earned per pound. Firm financing and construction progress on Thailand or Augusta would also count. Any of these would give a measurable earnings base and would call for a new valuation. For readers who remember earlier warnings: earlier filings raised substantial doubt about the company's ability to continue as a going concern. The February 2026 annual report says that doubt has been lifted, mainly because of the $300 million Series B sale. The June 2026 notes and stock sales added more cash.